The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Acetazolamide Market Research Report 2024
Synopsis
Acetazolamide, sold under the trade name Diamox among others, is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, and heart failure. It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out. It is taken by mouth or injection into a vein.
The global Acetazolamide market was valued at US$ 165.7 million in 2023 and is anticipated to reach US$ 206.1 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
North American market for Acetazolamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acetazolamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Acetazolamide include Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare and Strides Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Acetazolamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetazolamide.
Report Scope
The Acetazolamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acetazolamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acetazolamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Segment by Type
Tablets
Capsule
Injection
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acetazolamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acetazolamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Acetazolamide, sold under the trade name Diamox among others, is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, and heart failure. It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out. It is taken by mouth or injection into a vein.
The global Acetazolamide market was valued at US$ 165.7 million in 2023 and is anticipated to reach US$ 206.1 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
North American market for Acetazolamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Acetazolamide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Acetazolamide include Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare and Strides Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Acetazolamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetazolamide.
Report Scope
The Acetazolamide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acetazolamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acetazolamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
TARO
Zydus Pharmaceuticals
Lannett Company
Sun Pharmaceutical
Heritage Pharmaceuticals
Nostrum Laboratories
Accord Healthcare
Strides Pharma
West-Ward Pharmaceuticals
X-Gen Pharmaceuticals
Mylan
Emcure
Segment by Type
Tablets
Capsule
Injection
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acetazolamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acetazolamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Acetazolamide Market Overview
1.1 Product Overview and Scope of Acetazolamide
1.2 Acetazolamide Segment by Type
1.2.1 Global Acetazolamide Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Injection
1.3 Acetazolamide Segment by Application
1.3.1 Global Acetazolamide Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Acetazolamide Market Size Estimates and Forecasts
1.4.1 Global Acetazolamide Revenue 2019-2030
1.4.2 Global Acetazolamide Sales 2019-2030
1.4.3 Global Acetazolamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Acetazolamide Market Competition by Manufacturers
2.1 Global Acetazolamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Acetazolamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Acetazolamide Average Price by Manufacturers (2019-2024)
2.4 Global Acetazolamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Acetazolamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Acetazolamide, Product Type & Application
2.7 Acetazolamide Market Competitive Situation and Trends
2.7.1 Acetazolamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Acetazolamide Players Market Share by Revenue
2.7.3 Global Acetazolamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Acetazolamide Retrospective Market Scenario by Region
3.1 Global Acetazolamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Acetazolamide Global Acetazolamide Sales by Region: 2019-2030
3.2.1 Global Acetazolamide Sales by Region: 2019-2024
3.2.2 Global Acetazolamide Sales by Region: 2025-2030
3.3 Global Acetazolamide Global Acetazolamide Revenue by Region: 2019-2030
3.3.1 Global Acetazolamide Revenue by Region: 2019-2024
3.3.2 Global Acetazolamide Revenue by Region: 2025-2030
3.4 North America Acetazolamide Market Facts & Figures by Country
3.4.1 North America Acetazolamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Acetazolamide Sales by Country (2019-2030)
3.4.3 North America Acetazolamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Acetazolamide Market Facts & Figures by Country
3.5.1 Europe Acetazolamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Acetazolamide Sales by Country (2019-2030)
3.5.3 Europe Acetazolamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Acetazolamide Market Facts & Figures by Country
3.6.1 Asia Pacific Acetazolamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Acetazolamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Acetazolamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Acetazolamide Market Facts & Figures by Country
3.7.1 Latin America Acetazolamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Acetazolamide Sales by Country (2019-2030)
3.7.3 Latin America Acetazolamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Acetazolamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Acetazolamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Acetazolamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Acetazolamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Acetazolamide Sales by Type (2019-2030)
4.1.1 Global Acetazolamide Sales by Type (2019-2024)
4.1.2 Global Acetazolamide Sales by Type (2025-2030)
4.1.3 Global Acetazolamide Sales Market Share by Type (2019-2030)
4.2 Global Acetazolamide Revenue by Type (2019-2030)
4.2.1 Global Acetazolamide Revenue by Type (2019-2024)
4.2.2 Global Acetazolamide Revenue by Type (2025-2030)
4.2.3 Global Acetazolamide Revenue Market Share by Type (2019-2030)
4.3 Global Acetazolamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Acetazolamide Sales by Application (2019-2030)
5.1.1 Global Acetazolamide Sales by Application (2019-2024)
5.1.2 Global Acetazolamide Sales by Application (2025-2030)
5.1.3 Global Acetazolamide Sales Market Share by Application (2019-2030)
5.2 Global Acetazolamide Revenue by Application (2019-2030)
5.2.1 Global Acetazolamide Revenue by Application (2019-2024)
5.2.2 Global Acetazolamide Revenue by Application (2025-2030)
5.2.3 Global Acetazolamide Revenue Market Share by Application (2019-2030)
5.3 Global Acetazolamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Acetazolamide Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 TARO
6.2.1 TARO Corporation Information
6.2.2 TARO Description and Business Overview
6.2.3 TARO Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 TARO Acetazolamide Product Portfolio
6.2.5 TARO Recent Developments/Updates
6.3 Zydus Pharmaceuticals
6.3.1 Zydus Pharmaceuticals Corporation Information
6.3.2 Zydus Pharmaceuticals Description and Business Overview
6.3.3 Zydus Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zydus Pharmaceuticals Acetazolamide Product Portfolio
6.3.5 Zydus Pharmaceuticals Recent Developments/Updates
6.4 Lannett Company
6.4.1 Lannett Company Corporation Information
6.4.2 Lannett Company Description and Business Overview
6.4.3 Lannett Company Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lannett Company Acetazolamide Product Portfolio
6.4.5 Lannett Company Recent Developments/Updates
6.5 Sun Pharmaceutical
6.5.1 Sun Pharmaceutical Corporation Information
6.5.2 Sun Pharmaceutical Description and Business Overview
6.5.3 Sun Pharmaceutical Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Acetazolamide Product Portfolio
6.5.5 Sun Pharmaceutical Recent Developments/Updates
6.6 Heritage Pharmaceuticals
6.6.1 Heritage Pharmaceuticals Corporation Information
6.6.2 Heritage Pharmaceuticals Description and Business Overview
6.6.3 Heritage Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Heritage Pharmaceuticals Acetazolamide Product Portfolio
6.6.5 Heritage Pharmaceuticals Recent Developments/Updates
6.7 Nostrum Laboratories
6.6.1 Nostrum Laboratories Corporation Information
6.6.2 Nostrum Laboratories Description and Business Overview
6.6.3 Nostrum Laboratories Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nostrum Laboratories Acetazolamide Product Portfolio
6.7.5 Nostrum Laboratories Recent Developments/Updates
6.8 Accord Healthcare
6.8.1 Accord Healthcare Corporation Information
6.8.2 Accord Healthcare Description and Business Overview
6.8.3 Accord Healthcare Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Accord Healthcare Acetazolamide Product Portfolio
6.8.5 Accord Healthcare Recent Developments/Updates
6.9 Strides Pharma
6.9.1 Strides Pharma Corporation Information
6.9.2 Strides Pharma Description and Business Overview
6.9.3 Strides Pharma Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Strides Pharma Acetazolamide Product Portfolio
6.9.5 Strides Pharma Recent Developments/Updates
6.10 West-Ward Pharmaceuticals
6.10.1 West-Ward Pharmaceuticals Corporation Information
6.10.2 West-Ward Pharmaceuticals Description and Business Overview
6.10.3 West-Ward Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.10.4 West-Ward Pharmaceuticals Acetazolamide Product Portfolio
6.10.5 West-Ward Pharmaceuticals Recent Developments/Updates
6.11 X-Gen Pharmaceuticals
6.11.1 X-Gen Pharmaceuticals Corporation Information
6.11.2 X-Gen Pharmaceuticals Acetazolamide Description and Business Overview
6.11.3 X-Gen Pharmaceuticals Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.11.4 X-Gen Pharmaceuticals Acetazolamide Product Portfolio
6.11.5 X-Gen Pharmaceuticals Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Acetazolamide Description and Business Overview
6.12.3 Mylan Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Mylan Acetazolamide Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Emcure
6.13.1 Emcure Corporation Information
6.13.2 Emcure Acetazolamide Description and Business Overview
6.13.3 Emcure Acetazolamide Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Emcure Acetazolamide Product Portfolio
6.13.5 Emcure Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Acetazolamide Industry Chain Analysis
7.2 Acetazolamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Acetazolamide Production Mode & Process
7.4 Acetazolamide Sales and Marketing
7.4.1 Acetazolamide Sales Channels
7.4.2 Acetazolamide Distributors
7.5 Acetazolamide Customers
8 Acetazolamide Market Dynamics
8.1 Acetazolamide Industry Trends
8.2 Acetazolamide Market Drivers
8.3 Acetazolamide Market Challenges
8.4 Acetazolamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
